Vanina de Verneuil, EVP and General Counsel at Vir Biotechnology, Inc. (VIR), sold 3,750 shares at $9.47 ($32K) on 2024-11-05, disclosed to the SEC on 2024-11-05.
Scheduled sale ($32k) by EVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.20 | 1,403 | $10K | 31.2% |
| 2 | $9.47 | 2,347 | $22K | 68.8% |
| Total | $8.62 avg | 3,750 | $32K | 100% |
| Filing → |
| VIR | SELL | 2025-11-07 | $12K | — | Filing → |
| VIR | SELL | 2025-11-04 | $8K | — | Filing → |
| VIR | SELL | 2025-02-27 | $135K | — | Filing → |